Asia Pacific Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

List of Tables

The travel vaccines market in Asia Pacific is expected to grow from US$ 486.56 million in 2021 to US$ 1,023.07 million by 2028; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028.

Rising awareness related to the benefits of vaccines is the major factor leading to the growth of the travel vaccines market in the region. Most countries have mandated vaccination against various infectious diseases. However, there is a lack of awareness about vaccination in most low-and middle-income countries. Many countries conduct awareness campaigns for vaccination. In 2018, 17 countries in the Western Pacific region had celebrated "world immunization week" with the theme of "protected together VaccinesWork." Moreover, international organizations offer vaccines to children in low- and middle-income countries against pneumonia, HPV infections, and rotavirus in Asia Pacific. On the other hand, vaccination awareness is also an important part of the public health system among developed countries. Such initiatives are increasing the immunization and production of vaccines to offer growth opportunities for the market. Also, it will educate people regarding travel vaccines. As there has been an increase in travel across regions in search of better job opportunities and health, domestic and international travelers are always at a risk of exposing to infectious diseases and may transmit them to others before or after travel. Therefore, such initiatives and programs are creating a scope for travel vaccines and establish a robust market in low- and middle-income countries.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific travel vaccines market. The Asia Pacific travel vaccines market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Travel Vaccines Market Segmentation

Asia Pacific travel vaccines market is segmented into product, application, and country. The Asia Pacific travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Asia Pacific travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest market share. Based on country, the Asia Pacific travel vaccines market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific.

Abbott; Bharat Biotech; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC travel vaccines market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC travel vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the travel vaccines market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025509

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 APAC Travel Vaccines Market - By Product
- 1.3.2 APAC Travel Vaccines Market - By Application
- 1.3.3 APAC Travel Vaccines Market - By Country

2. APAC Travel Vaccines Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. APAC Travel Vaccines Market- Market Landscape

4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion

5. APAC Travel Vaccines Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Travel and Tourism on Rise
- 5.1.2 Surge in Incidences of Infectious Diseases
5.2 Market Restraints
- 5.2.1 High Cost of Travel Vaccines
5.3 Market Opportunities
- 5.3.1 Rising Awareness Regarding Vaccines
5.4 Future Trends
- 5.4.1 Never-ending Demand for Vaccines
5.5 Impact Analysis

6. Travel Vaccines Market - APAC Analysis

6.1 APAC Travel Vaccines Marker Revenue Forecast and Analysis

7. APAC Travel Vaccines Market Analysis - By Product

7.1 Overview
7.2 APAC Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
- 7.3.1 Overview
- 7.3.2 Hepatitis A: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Hepatitis B
- 7.4.1 Overview
- 7.4.2 Hepatitis B: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Meningococcal Vaccines
- 7.5.1 Overview
- 7.5.2 Meningococcal Vaccines: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)

8. APAC Travel Vaccines Market Analysis - By Application

8.1 Overview
8.2 APAC Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Domestic Travel
- 8.3.1 Overview
- 8.3.2 Domestic Travel: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Outbound Travel
- 8.4.1 Overview
- 8.4.2 Outbound Travel: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)

9. APAC Travel Vaccines Market - Country Analysis

9.1 Overview
- 9.1.1 APAC: Travel Vaccines Market, by Country, 2020 & 2028 (%)
  - 9.1.1.1 China: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.1.1 China: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.1.2 China: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.1.3 China: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.2 Japan: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.2.1 Japan: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.2.2 Japan: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.2.3 Japan: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.3 India: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.3.1 India: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.3.2 India: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.3.3 India: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.4 Australia: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.4.1 Australia: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.4.2 Australia: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.4.3 Australia: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.5 South Korea: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.5.1 South Korea: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.5.2 South Korea: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.5.3 South Korea: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.6 Rest of APAC: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.6.1 Rest of APAC: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.6.2 Rest of APAC: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.6.3 Rest of APAC: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)

10. Travel Vaccines Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Travel Vaccines Market, (%)
10.3 Organic Developments
- 10.3.1 Overview
10.4 Inorganic Developments
- 10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Merck & Co., Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Novartis AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Pfizer Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Emergent BioSolutions Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Abbott
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 BHARAT BIOTECH
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About the Insight Partners
12.2 Glossary of Terms